ArticlePublished 3 May 2019
Formulation and Evaluation of Nanostructured Lipid Carrier (NLC) For Glimepiride.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanostructured lipid carriers (NLC) of Glimepiride was prepared with the objective of treating type-2 diabetes. The formulated NLC consist of Compritol ATO 888 as solid lipid, medium chain triglycerides as liquid lipid and poloxamer 188 as surfactant. NLC’s were prepared by using hot homogenization technique and characterized by FT-IR, DSC. All NLC had shown entrapment efficiency within a range of 78.52 to 90.38%. Both entrapment efficiency and release rate was effected by lipid concentration. Formulation F5 was considered as an optimized formulation based on its particle size and % drug release. Zeta potential value had suggested good particle stability. The optimized formulation did not show any physical/chemical changes when it is subjected to accelerated stability conditions. It was concluded that formulated NLC holds as a potential approach for controlled release of drug which may reduce the dose frequency and improves patient compliance.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sivadasu Praveen”
- BylineArticles whose byline prints “D. V. Gowda”
- BylineArticles whose byline prints “Atul Srivastava”
- BylineArticles whose byline prints “Riyaz Ali M. Osmani”